Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet

Journal of Inflammation

Volumn 4, Issue , 2007, Pages

  Huang, Hong ^a,c   Liu, Tongzheng ^a   Rose, Jane L ^a   Stevens, Rachel L ^a   Hoyt, Dale G ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLOID A PROTEIN; ASPARTATE AMINOTRANSFERASE; CD14 ANTIGEN; ENDOTOXIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIVER ENZYME; MESSENGER RNA; SATURATED FATTY ACID; STAT1 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; C57BL 6 MOUSE; CHOLESTEROL DIET; FEMALE; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIVER INJURY; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS;

MUS;

EID: 38049023478     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-4-22     Document Type: Article

References (60)

1. Response of liver genes to acute phase mediators. GJ Darlington DR Wilson M Revel JH Kelly, Ann N Y Acad Sci 1989 557 310 5; discussion 315-6 2472091
2. Effects of initial passage of endotoxin through the liver on the extent of acute lung injury in a rat model. H Shimada N Hasegawa H Koh S Tasaka M Shimizu W Yamada T Nishimura K Amakawa M Kohno M Sawafuji K Nakamura S Fujishima K Yamaguchi A Ishizaka, Shock 2006 26 311 315 10.1097/01.shk.0000224960.17274. 6f 16912658
3. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. JF Berbee LM Havekes PC Rensen, J Endotoxin Res 2005 11 97 103 15949136
4. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. RL Kitchens PA Thompson S Viriyakosol GE O'Keefe RS Munford, J Clin Invest 2001 108 485 493 11489942 10.1172/JCI200113139
5. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. RL Kitchens PA Thompson, J Endotoxin Res 2003 9 113 118 12803885
6. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. RL Kitchens PA Thompson, J Endotoxin Res 2005 11 225 229 16176659
7. The role of cytokine mediators in septic shock. KJ Tracey SF Lowry, Adv Surg 1990 23 21 56 2403458
8. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. DM Steel AS Whitehead, Immunol Today 1994 15 81 88 10.1016/0167-5699(94)90138-4 8155266
9. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. ES Van Amersfoort TJ Van Berkel J Kuiper, Clin Microbiol Rev 2003 16 379 414 12857774 10.1128/CMR.16.3.379-414.2003
10. Effects of nitric oxide in septic shock. JL Vincent H Zhang C Szabo JC Preiser, Am J Respir Crit Care Med 2000 161 1781 1785 10852744
11. p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-gamma through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells. H Huang JL Rose DG Hoyt, Mol Pharmacol 2004 66 302 311 10.1124/mol.66.2.302 15266021
12. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. QW Xie R Whisnant C Nathan, J Exp Med 1993 177 1779 1784 10.1084/jem.177.6.1779 7684434
13. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. R Deshpande H Khalili RG Pergolizzi SD Michael MD Chang, Am J Reprod Immunol 1997 38 46 54 9266010
14. Negative transcriptional regulation of the VCAM-1 gene by fluid shear stress in murine endothelial cells. R Korenaga J Ando K Kosaki M Isshiki Y Takada A Kamiya, Am J Physiol 1997 273 C1506 15 9374635
15. Inhibition of host resistance by nutritional hypercholesteremia. WL Kos RM Loria MJ Snodgrass D Cohen TG Thorpe AM Kaplan, Infect Immun 1979 26 658 667 317596
16. Altered immune function in hypercholesterolemic monkeys. RH Fiser Jr. JC Denniston VG McGann J Kaplan WH Alder 3rd MD Kastello WR Beisel, Infect Immun 1973 8 105 109 4198100
17. Alterations of host defenses paralleling cholesterol-induced atherogenesis. I. Interactions of prolonged experimental hypercholesterolemia and infections. DM Klurfeld MJ Allison E Gerszten HP Dalton, J Med 1979 10 35 48 290725
18. Alterations of host defenses paralleling cholesterol-induced atherogenesis. II. Immunologic studies of rabbits. Anonymous, J Med 1979 10 49 64 314965
19. Increased susceptibility of mice to MHV 3 infection induced by hypercholesterolemic diet: impairment of Kupffer cell function. CA Pereira AM Steffan F Koehren CR Douglas A Kirn, Immunobiology 1987 174 253 265 3623605
20. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. L Vergnes J Phan M Strauss S Tafuri K Reue, J Biol Chem 2003 278 42774 42784 10.1074/jbc.M306022200 12923166
21. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. DD Henninger ME Gerritsen DN Granger, Circ Res 1997 81 274 281 9242189
22. Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. JC Fleet SK Clinton RN Salomon H Loppnow P Libby, J Nutr 1992 122 294 305 1732470
23. Increased lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits. BE Brito EL Romano C Grunfeld, Clin Exp Immunol 1995 101 357 361 7648721
24. Hypercholesterolemia alters endotoxin-induced endothelial cell adhesion molecule expression. WH Cerwinka MH Cheema DN Granger, Shock 2001 16 44 50 11442315
25. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. S Kim I Sohn JI Ahn KH Lee YS Lee, Gene 2004 340 99 109 10.1016/j.gene.2004.06.015 15556298
26. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. XH Xu PK Shah E Faure O Equils L Thomas MC Fishbein D Luthringer XP Xu TB Rajavashisth J Yano S Kaul M Arditi, Circulation 2001 104 3103 3108 10.1161/hc5001.100631 11748108
27. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. K Edfeldt J Swedenborg GK Hansson ZQ Yan, Circulation 2002 105 1158 1161 11889007
28. Toll Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity. F Kim M Pham I Luttrell DD Bannerman J Tupper J Thaler TR Hawn EW Raines MW Schwartz, Circ Res 2007 100 1589 1596 10.1161/CIRCRESAHA.106.142851 17478729
29. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. RJ Henry N Chiamori OJ Golub S Berkman, Am J Clin Pathol 1960 34 381 398 13713438
30. Quantification of endotoxin inhibition in serum and plasma using a turbidimetric LAL assay. TJ Novitsky PF Roslansky, Prog Clin Biol Res 1985 189 181 196 4048203
31. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. MM Bradford, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
32. Manual of Histological Staining Methods of the Armed Forces Institute of Pathology. LG Luna, New York, McGraw-Hill, Inc, Luna LG, 3rd 1968
33. Statistical Methods, 7th ed. GW Snedecor WG Cochran, Ames, IA, Iowa State University Press 1980
34. Proteomic analysis of diet-induced hypercholesterolemic mice. JY Park JK Seong YK Paik, Proteomics 2004 4 514 523 10.1002/pmic.200300623 14760724
35. Mutational switch of an IL-6 response to an interferon-gamma-like response. AP Costa-Pereira S Tininini B Strobl T Alonzi JF Schlaak H Is'harc I Gesualdo SJ Newman IM Kerr V Poli, Proc Natl Acad Sci U S A 2002 99 8043 8047 12060750 10.1073/pnas.122236099
36. Distribution of endotoxin (lipopolysaccharide) in the tissues of lipopolysaccharide-responsive and -unresponsive mice. RA Musson DC Morrison RJ Ulevitch, Infect Immun 1978 21 448 457 689731
37. Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium. M Matsuura C Galanos, Infect Immun 1990 58 935 937 2180825
38. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. SC Whitman P Ravisankar H Elam A Daugherty, Am J Pathol 2000 157 1819 1824 11106554
39. The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. G Fantuzzi CA Dinarello, J Leukoc Biol 1996 59 489 493 8613694
40. Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat. S Bedoui E Velkoska S Bozinovski JE Jones GP Anderson MJ Morris, J Inflamm (Lond) 2005 2 2 15813957 10.1186/1476-9255-2-2
41. LPS-induced release of IL-1beta, IL-1Ra, IL-6, and TNF-alpha in whole blood from patients with familial hypercholesterolemia: no effect of cholesterol-lowering treatment. N de Bont MG Netea C Rovers T Smilde A Hijmans PN Demacker JW van der Meer AF Stalenhoef, J Interferon Cytokine Res 2006 26 101 107 10.1089/jir.2006.26.101 16487030
42. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. WG Girod SP Jones N Sieber TY Aw DJ Lefer, Arterioscler Thromb Vasc Biol 1999 19 2776 2781 10559025
43. Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis. M Kainuma M Fujimoto N Sekiya K Tsuneyama C Cheng Y Takano K Terasawa Y Shimada, J Gastroenterol 2006 41 971 980 10.1007/s00535-006-1883-1 17096066
44. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. K Kinugawa T Shimizu A Yao O Kohmoto T Serizawa T Takahashi, Circ Res 1997 81 911 921 9400371
45. Signal transduction by tumor necrosis factor and its relatives. V Baud M Karin, Trends Cell Biol 2001 11 372 377 10.1016/S0962-8924(01)02064-5 11514191
46. Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. HW Harris SE Brady JH Rapp, J Surg Res 2002 106 188 195 10.1006/jsre.2002.6413 12127825
47. Role for circulating lipoproteins in protection from endotoxin toxicity. KR Feingold JL Funk AH Moser JK Shigenaga JH Rapp C Grunfeld, Infect Immun 1995 63 2041 2046 7729918
48. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. TE Read HW Harris C Grunfeld KR Feingold JP Kane JH Rapp, Eur Heart J 1993 14 Suppl K 125 129 8131781
49. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. C Baumberger RJ Ulevitch JM Dayer, Pathobiology 1991 59 378 383 1930690
50. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. D Pajkrt JE Doran F Koster PG Lerch B Arnet T van der Poll JW ten Cate SJ van Deventer, J Exp Med 1996 184 1601 1608 10.1084/jem.184.5.1601 8920850
51. In vivo protection against endotoxin by plasma high density lipoprotein. DM Levine TS Parker TM Donnelly A Walsh AL Rubin, Proc Natl Acad Sci U S A 1993 90 12040 12044 8265667 10.1073/pnas.90.24.12040
52. Lipoproteins in inflammation and sepsis. I. Basic science. O Murch M Collin CJ Hinds C Thiemermann, Intensive Care Med 2007 33 13 24 10.1007/s00134-006-0432-y 17093985
53. Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor alpha responses to lipopolysaccharide in rabbits. JI Cue JT DiPiro LJ Brunner JE Doran ME Blankenship AR Mansberger ML Hawkins, Arch Surg 1994 129 193 197 8304830
54. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock. ZM Quezado C Natanson SM Banks DW Alling CA Koev RL Danner RJ Elin JM Hosseini TS Parker DM Levine, J Pharmacol Exp Ther 1995 272 604 611 7853173
55. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. HW Harris C Grunfeld KR Feingold JH Rapp, J Clin Invest 1990 86 696 702 2394827
56. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. JF Berbee CC van der Hoogt R Kleemann EF Schippers RL Kitchens JT van Dissel IA Bakker-Woudenberg LM Havekes PC Rensen, Faseb J 2006 20 2162 2164 10.1096/fj.05-5639fje 16935938
57. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. A Kontush MJ Chapman, Pharmacol Rev 2006 58 342 374 10.1124/pr.58.3.1 16968945
58. Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression. D Ashby J Gamble M Vadas N Fidge S Siggins K Rye PJ Barter, Atherosclerosis 2001 154 113 121 10.1016/S0021-9150(00)00437-8 11137089
59. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. PA Thompson RL Kitchens, J Immunol 2006 177 4880 4887 16982930
60. Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. JG Bieri GS Stoewsand GM Briggs RW Phillips JC Woodard JJ Knapka, J Nutr 1977 107 1340 1348 874577